image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CN
$ 3.78
23.2 %
$ 818 K
Market Cap
None
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one UPC stock under the worst case scenario is HIDDEN Compared to the current market price of 3.78 USD, Universe Pharmaceuticals INC is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one UPC stock under the base case scenario is HIDDEN Compared to the current market price of 3.78 USD, Universe Pharmaceuticals INC is HIDDEN

This DCF valuation model was last updated on Apr, 22, 2025.

The intrinsic value of one UPC stock under the best case scenario is HIDDEN Compared to the current market price of 3.78 USD, Universe Pharmaceuticals INC is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart UPC

image
$200.0$200.0$180.0$180.0$160.0$160.0$140.0$140.0$120.0$120.0$100.0$100.0$80.0$80.0$60.0$60.0$40.0$40.0$20.0$20.0$0.0$0.0Nov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '2515 Apr15 Apr
FINANCIALS
32.3 M REVENUE
-19.52%
-3.53 M OPERATING INCOME
49.76%
-6.16 M NET INCOME
29.46%
1.12 M OPERATING CASH FLOW
185.35%
-44.2 K INVESTING CASH FLOW
98.87%
-1.39 M FINANCING CASH FLOW
-41.91%
12.9 M REVENUE
-6.92%
-1.74 M OPERATING INCOME
52.66%
-13.1 M NET INCOME
-140.50%
-2.43 M OPERATING CASH FLOW
33.25%
-67.7 K INVESTING CASH FLOW
-55.45%
6.07 M FINANCING CASH FLOW
274.78%
Balance Sheet Universe Pharmaceuticals INC
image
Current Assets 36.8 M
Cash & Short-Term Investments 18.5 M
Receivables 10.7 M
Other Current Assets 7.58 M
Non-Current Assets 16.5 M
Long-Term Investments 685 K
PP&E 15 M
Other Non-Current Assets 806 K
34.73 %20.13 %14.22 %28.12 %Total Assets$53.3m
Current Liabilities 13.8 M
Accounts Payable 4.59 M
Short-Term Debt 5.48 M
Other Current Liabilities 3.69 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
33.34 %39.86 %26.80 %Total Liabilities$13.8m
EFFICIENCY
Earnings Waterfall Universe Pharmaceuticals INC
image
Revenue 32.3 M
Cost Of Revenue 22 M
Gross Profit 10.3 M
Operating Expenses 13.8 M
Operating Income -3.53 M
Other Expenses 2.64 M
Net Income -6.16 M
35m35m30m30m25m25m20m20m15m15m10m10m5m5m00(5m)(5m)(10m)(10m)32m(22m)10m(14m)(4m)(3m)(6m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
31.93% GROSS MARGIN
31.93%
-10.92% OPERATING MARGIN
-10.92%
-19.08% NET MARGIN
-19.08%
-15.59% ROE
-15.59%
-11.57% ROA
-11.57%
-12.54% ROIC
-12.54%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Universe Pharmaceuticals INC
image
15m15m10m10m5m5m00(5m)(5m)(10m)(10m)(15m)(15m)(20m)(20m)201920192020202020212021202220222023202320242024
Net Income -6.16 M
Depreciation & Amortization 509 K
Capital Expenditures -44.2 K
Stock-Based Compensation 0
Change in Working Capital 6.62 M
Others 919 K
Free Cash Flow 1.08 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Universe Pharmaceuticals INC
image
UPC has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 5
6. Ownership
Insider Ownership Universe Pharmaceuticals INC
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Universe Pharmaceuticals INC Announces Share Consolidation Jiangxi, China, March 20, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company plans to effect a share consolidation of 40 ordinary shares with par value of US$0.28125 per share each in the Company's issued and unissued share capital into one (1) ordinary share with par value of US$11.25 (the “Share Consolidation”). As a result of the Share Consolidation, each 40 pre-consolidation ordinary shares outstanding will automatically combine and convert to one issued and outstanding ordinary share without any action on the part of the shareholders. globenewswire.com - 1 month ago
Universe Pharmaceuticals INC Receives Staff Determination Notice from Nasdaq Related to Delayed Annual Report Ji'an, Jiangxi, China, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that on February 19, 2025, the Company received a staff determination notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it is delinquent in filing its Annual Report on Form 20-F for the fiscal year ended September 30, 2024 (the “Form 20-F”) and that this matter serves as an additional basis for delisting the Company's securities from Nasdaq. The failure to timely file the Form 20-F is a violation of Nasdaq Listing Rule 5250(c)(1). globenewswire.com - 2 months ago
Universe Pharmaceuticals INC Receives Nasdaq Delisting Notice Subject to Hearing Request Ji'an, Jiangxi, China, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) on January 29, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the “Delisting Determination”), because the bid price of the Company's listed securities has closed at less than $1 per share over the previous 30 consecutive business days, and therefore no longer complies with the Nasdaq Listing Rule 5550(a)(2) (the “Rule”). Normally, a company would be afforded a 180-calendar day period to demonstrate compliance with the Rule. However, pursuant to the Nasdaq Listing Rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period specified in Nasdaq Listing Rule 5810(c)(3)(A) due to the fact that the Company effected a reverse stock split on November 18, 2024, or within the prior one-year period. globenewswire.com - 3 months ago
Univest Securities, LLC Announces Closing of $15 Million Registered Direct Offering for its Client Universe Pharmaceuticals INC (NASDAQ: UPC) New York, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of registered direct offering (the “Offering”) of its client Universe Pharmaceuticals INC (NASDAQ: UPC) (the “Company”), a pharmaceutical producer and distributor in China. globenewswire.com - 4 months ago
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency Ji'an, Jiangxi, China, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the "Notification Letter") from the Nasdaq Stock Market LLC ("Nasdaq") on October 25, 2024, notifying the Company that it is not in compliance with the minimum bid price requirement set forth in the Nasdaq Listing Rules for continued listing on the Nasdaq. globenewswire.com - 6 months ago
“I Will Make UPC Great Again!”—UPC Presidential Hopeful Othieno Vows as He Praises Obote’s Legacy Appearing on the NBS political program ‘People and Power’ yesterday, Joseph Othieno, a candidate for the Uganda People’s Congress (UPC) presidency, painted a picture of the party’s historical journey and his role in shaping its direction as He praised the party’s founder, Milton Obote, for being a key figure in Uganda’s political history, describing him […] The post “I Will Make UPC Great Again!”—UPC Presidential Hopeful Othieno Vows as He Praises Obote’s Legacy appeared first on Watchdog Uganda... watchdoguganda.com - 6 months ago
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024 JI'AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its unaudited financial results for the first six months of fiscal year 2024 ended March 31, 2024. globenewswire.com - 7 months ago
UPC Tasks President Museveni to Produce Evidence of Vote Rigging in Courts of Law Uganda People’s Congress (UPC) has tasked President Yoweri Museveni to produce evidence of the 2021 Presidential elections, in which the President recently said his votes were rigged by 1 million votes by the National Unity Platform (NUP). UPC Spokesperson, Sharon Oyat Arach, made the call during a press conference, held at the UPC Head office […] The post UPC Tasks President Museveni to Produce Evidence of Vote Rigging in Courts of Law appeared first on Watchdog Uganda... watchdoguganda.com - 7 months ago
UPC Concerned over Welfare of Medical Interns Uganda People’s Congress (UPC) has raised concerns on the wellbeing of Medical Interns. The UPC concerns were voiced in a statement released on Wednesday, during a Press Conference at the UPC Head Office located on Uganda House in Kampala. “President Yoweri Museveni last week made a pronouncement that there are no funds for medical interns […] The post UPC Concerned over Welfare of Medical Interns appeared first on Watchdog Uganda... watchdoguganda.com - 8 months ago
UPC Calls on Government to Impact Skills Development Education in Youth Uganda People’s Congress (UPC) has called on the Government to put into place the necessary education and skills development in youth to enable them to grow up as reproductive and responsible citizens. The call was made at a press conference, held on Wednesday at the UPC Head office, located in Uganda House in Kampala City. […] The post UPC Calls on Government to Impact Skills Development Education in Youth appeared first on Watchdog Uganda... watchdoguganda.com - 8 months ago
UPC Raises Red Flag on Road Carnage, City Robberies Uganda People’s Congress (UPC) on Wednesday raised concerns about the Traffic Police Report that revealed that over 80 people died in road accidents in just a period of one week from 7th – 13th July, 2024. “The Party extends heartfelt condolences to families that lost their loved ones in such fatal accidents and quick recovery to those hospitalized […] The post UPC Raises Red Flag on Road Carnage, City Robberies appeared first on Watchdog Uganda... watchdoguganda.com - 9 months ago
UPC Condemns Re- Arrest of Legislator Released on Bail for Corruption Charges The Uganda People’s Congress (UPC) has condemned with strongest terms the immediate re-arrest of Hon. Akamba Paul (Busiki County) by security operatives, immediately the legislature was granted bail by the competent Court of Law on charges of corruption. The condemnation of this act was voiced by UPC in a weekly press briefing held at the […] The post UPC Condemns Re- Arrest of Legislator Released on Bail for Corruption Charges appeared first on Watchdog Uganda... watchdoguganda.com - 10 months ago
8. Profile Summary

Universe Pharmaceuticals INC UPC

image
COUNTRY CN
INDUSTRY Drug Manufacturers - Specialty & Generic
MARKET CAP $ 818 K
Dividend Yield 0.00%
Description Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Contact No. 265, Jingjiu Avenue, Ji'An, 343100 https://www.universe-pharmacy.com
IPO Date March 23, 2021
Employees 225
Officers Mr. Gang Lai Chief Executive Officer & Chairman Mr. Baochang Liu Chief Operating Officer Ms. Lin Yang Chief Financial Officer & Director